Vyome Holdings, Inc. (HIND) Stock Analysis

Vyome Holdings, Inc. (HIND) is a publicly traded company in the HEALTHCARE sector. It trades at $2.30, carries a market capitalization of $16.42M. This page summarizes the public market data, fundamentals, and frequently asked questions for HIND, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.30
• Market Cap: $16.42M
• EPS: $-1.56
• 52-Week High: $23.68
• 52-Week Low: $1.75

About Vyome Holdings, Inc.

Vyome Holdings, Inc. (Ticker: HIND) is a clinical-stage biopharmaceutical company focused on developing innovative therapeutic solutions for immuno-inflammatory and rare diseases. Based in Princeton, New Jersey, Vyome leverages cutting-edge research and advanced technologies to address unmet medical needs in the United States and international markets. The company's pipeline emphasizes its commitment to delivering impactful treatments, positioning it as a key player in the evolving landscape ...

GNG Research Analysis

GNG Research scores Vyome Holdings, Inc. (HIND) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for HIND.

Frequently Asked Questions

Does HIND pay dividends?

Vyome Holdings, Inc. (HIND) does not currently pay a regular dividend.

What is HIND's market cap?

Vyome Holdings, Inc. (HIND) has a market capitalization of $16.42M with a current stock price of $2.30.